Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Investig Drugs. 2003 Aug;4(8):1010-8.

    Oral typhoid vaccine. Acambis/Berna.

    Source

    Questcor Pharmaceuticals Inc, 3260 Whipple Road, Union City, CA 94587-1217, USA. gwitherell@questcor.com

    Abstract

    Acambis and Berna are developing HolaVax-Typhoid, a single-dose, live attenuated oral vaccine for the potential prophylaxis of typhoid. A phase II trial was successfully completed in January 1999, and in September 2002, Acambis announced that a bridging trial was planned for the first half of 2003 to confirm that the vaccine produced by Berna was equivalent to the typhoid vaccine that had been studied previously.

    PMID:
    14508886
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk